ClinicalTrials.gg
CompletedNCT03837639Updated Nov 3, 2026

Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery Disease

An interventional study of Arm ergometer and Treadmill ergometer in Peripheral Arterial Disease, Intermittent Claudication and Hypertension, sponsored by Hospital Israelita Albert Einstein. Completed at 1 site in Brazil. Open to participants aged 45 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Primary conditionIntermittent ClaudicationRegistry: Peripheral Arterial DiseaseReclassifiedWhy we changed it
Registry
Peripheral Arterial Disease — the first condition term the registry derived for this study.
ClinicalTrials.gg
Intermittent Claudication
Why
  1. The study's listed conditions name Intermittent Claudication, a narrower term within Peripheral Arterial Disease.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Hospital Israelita Albert Einstein · Not applicable, Interventional, and Treatment

How we know

Updated Nov 3, 2026Now CompletedStart date moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
45 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Intermittent Claudication with a site in Brazil — 1 open to participants now, 1 under way, none of them phase 3. Intermittent Claudication · Brazil.

Started
2019
the only one that year
No phase
6 of 10
1 open now
Registered
6th of 10
by date
Lead sponsor
1 of 10
Hospital Israelita Albert Einstein

Among the 10 studies in Intermittent Claudication with a site in Brazil, this one is the only one that started in 2019, is one of 6 with no phase, and was the 6th registered.

Intermittent Claudication

309 studies on the registry are indexed under Intermittent Claudication; 46 are open to participants now.

Browse Intermittent Claudication studies →

Open to participants now

1 of the 10 studies in Intermittent Claudication with a site in Brazil is open now. Recruiting first, the newest first:

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 33 Intermittent Claudication studies recruiting now, 21 (64%) set no upper age limit and none (0%) stop at 75 or younger; none take children under 18; 1 takes healthy volunteers.

This study: 45 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Intermittent Claudication with a site in Brazil, or all of them as a file.
02

Study summary

The aim of the study is to analyze the effect of 12 weeks of arm crank exercise (ACE) training on cardiovascular function in PAD patients, and compare it with treadmill exercise (TE), the actual recommendation for this patients. In this clinical trial, 45 patients will be allocated randomly in three experimental groups: ACE training, TE and control group. ACE and TE groups will perform exercises twice a week with the intensity equivalent to 13- 15 on Borg's Subjective Perception Exertion Scale. Patients in control group will meet twice a week, however only to perform diverse activities and group living, without any type of exercise involved. All groups will be encouraged to increase their levels of activity, as they are usually guided in medical consultations. Before and after 12 weeks of intervention, cardiovascular function, functional capacity, cognition, and quality of life will be assessed.

Read the detailed description

Arm-crank exercise (ACT) is an alternative exercise strategy for patients with symptomatic peripheral artery disease (PAD) due the benefits on functional capacity and quality of life, besides provoking less or no pain symptoms during the execution. This study sought to describe the protocol of a study that will analyse the effect of ACT exercise on walking capacity, cardiovascular function, cognition and quality of life in patients with symptomatic PAD.

This is a three-armed randomized, prospective, single-blind data collection, single-center, controlled study enrolling 45 patients with symptomatic PAD which will be randomized into 3 intervention groups: walking training (WT), ACT (WT and AC: 15 to 10 sets of 2 to 5 minutes, Borg 13 to 15) and control group (CG). Before and after 12 weeks of intervention, cardiovascular function (ambulatory blood pressure , clinic blood pressure, central blood pressure, heart rate variability, arterial stiffness, vascular function), functional capacity (six-minute walking test, 2 minute step test [2 MST], Walking impairment questionnaire [WIQ], Walking estimated limitation calculated by history [WELCH], Baltimore activity scale for intermittent claudication, handgrip test and short physical performance battery [SPPB]), cognition (executive function and memory) and quality of life (short version of world health organization quality of life and vascular quality of life questionnaire [VASCUQOL-6]) will be assessed.

This is the first trial to evaluate the effects of ACT on regulatory mechanisms of cardiovascular system in PAD patients. If the results are as expected, they will provide evidence of ACT in promoting cardiovascular benefits in symptomatic PAD population.

03

Conditions studied

  • Peripheral Arterial Disease
  • Intermittent Claudication
  • Hypertension

Browse trials for

Keywords

  • arm-crank
  • exercise training
  • cardiovascular function
04

In context

Intermittent Claudication Reclassified

309 studies on the registry are indexed under Intermittent Claudication; 46 are open to participants now.

This study's enrollment of 90 is above the median of 74 across 242 interventional studies indexed under Intermittent Claudication.

Browse Intermittent Claudication studies →

Lead sponsor

Hospital Israelita Albert Einstein is the lead sponsor of 147 studies on the registry; 32 are open to participants now.

Compared within Intermittent Claudication, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Peripheral Arterial Disease. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
45 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • PAD stage II
  • Ankle brachial index \<0.90 in one or both lower limbs;
  • Women in phase without hormone replacement therapy
  • Not an active smoker;
  • Able to perform exercise training;

Patients selected to participate in the study will be only excluded if:

  • Change their medication;
  • Present any health impairment that contraindicates the practice of physical exercise during the study;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Arm crank ergometer

    Arm-crank exercise group will be performed twice a week for 12 weeks. In the first weeks of training, each session will consist of 15 bouts, two active minutes and two minutes of passive interval, consisting of 60 minutes of session (30 minutes of active exercise). After the first three weeks of training, the exercise time will progressively increase by one minute every 3 weeks and the recovery period will be decreased, completing, at the end, a maximum volume of 10 bouts of five minutes of exercise and one minute of passive interval. The intensity of the exercise will be determined by the load equivalent to the range of 13 - 15 of The Borg Rating of Perceived Exertion, considered as somewhat hard to hard.

    Other: Arm ergometer

  • Experimental
    Treadmill ergometer

    Walking exercise group will be performed twice a week for 12 weeks. In the first weeks of training, each session will consist of 15 bouts, two active minutes and two minutes of passive interval, consisting of 60 minutes of session (30 minutes of active exercise). After the first three weeks of training, the exercise time will progressively increase by one minute every 3 weeks and the recovery period will be decreased, completing, at the end, a maximum volume of 10 bouts of five minutes of exercise and one minute of passive interval. The intensity of the exercise will be determined by the load equivalent to the range of 13 - 15 of The Borg Rating of Perceived Exertion, considered as somewhat hard to hard.

    Other: Treadmill ergometer

  • Other
    Control group

    Patients randomized to control group will attend to meetings with the researcher team twice a week during the 12 weeks. At these meetings, patients will perform manual tasks, with or without the use of artistic materials, cultural programs, cooking classes and home care, without any exercise component. This CG practice will be performed in order to minimize the effects of the patient's bi- weekly commitment and displacement to the training site, to minimize the influence of the patient- researcher contact and also minimize the convivial effect among the patients themselves, which will occur in the other two groups.

    Other: Control group

Interventions

  • OtherArm ergometer

    Arm-crank exercise group will be performed twice a week for 12 weeks. In the first weeks of training, each session will consist of 15 bouts, two active minutes and two minutes of passive interval, consisting of 60 minutes of session (30 minutes of active exercise). After the first three weeks of training, the exercise time will progressively increase by one minute every 3 weeks and the recovery period will be decreased, completing, at the end, a maximum volume of 10 bouts of five minutes of exercise and one minute of passive interval. The intensity of the exercise will be determined by the load equivalent to the range of 13 - 15 of The Borg Rating of Perceived Exertion, considered as somewhat hard to hard

  • OtherTreadmill ergometer

    Walking exercise group will be performed twice a week for 12 weeks. In the first weeks of training, each session will consist of 15 bouts, two active minutes and two minutes of passive interval, consisting of 60 minutes of session (30 minutes of active exercise). After the first three weeks of training, the exercise time will progressively increase by one minute every 3 weeks and the recovery period will be decreased, completing, at the end, a maximum volume of 10 bouts of five minutes of exercise and one minute of passive interval. The intensity of the exercise will be determined by the load equivalent to the range of 13 - 15 of The Borg Rating of Perceived Exertion, considered as somewhat hard to hard.

  • OtherControl group

    Patients randomized to control group will attend to meetings with the researcher team twice a week during the 12 weeks. At these meetings, patients will perform manual tasks, with or without the use of artistic materials, cultural programs, cooking classes and home care, without any exercise component. This CG practice will be performed in order to minimize the effects of the patient's bi- weekly commitment and displacement to the training site, to minimize the influence of the patient- researcher contact and also minimize the convivial effect among the patients themselves, which will occur in the other two groups.

07

What researchers measure

Primary outcomes

  1. ambulatory blood pressure

    Systolic, diastolic and mean blood pressure will be measured before and after 12 weeks of intervention period on intervention and control group by an automatic ambulatory blood pressure monitor (Cardios, São Paulo, Brazil).

    Time frame: Change from baseline in ambulatory blood pressure at 12 weeks

Secondary outcomes

  1. Clinic blood pressure

    Systolic and diastolic brachial blood pressure will be measured before and after 12 weeks of intervention period on intervention and control group by an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan).

    Time frame: Change from baseline in ambulatory blood pressure at 12 weeks

  2. Central blood pressure

    Systolic and diastolic central blood pressure will be measured before and after 12 weeks of intervention period on intervention and control group by an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan).

    Time frame: Change from baseline in ambulatory blood pressure at 12 weeks

  3. Heart rate variability

    Heart rate variability will be measured before and after 12 weeks of intervention period on intervention and control group by heart rate monitor (Polar, RS 800, USA).

    Time frame: Change from baseline in ambulatory blood pressure at 12 weeks

  4. Arterial stiffness

    Carotid femoral pulse wave velocity will be measured before and after 12 weeks of intervention period on intervention and control group by pulse wave velocity measurement with applanation tonometry (SphygmoCor, AtCor Medical, Australia).

    Time frame: Change from baseline in arterial stiffness at 12 weeks

  5. Vascular function

    Flow-meadiated dilation will be measured before and after 12 weeks of intervention period on intervention and control group by a flow mediated dilation measurement with an ultrasound image (HDI 5000 Sono CT, Philips, The Netherlands).

    Time frame: Change from baseline in flow-mediated vasodilation at 12 weeks

  6. Walking capacity

    Six-minute walking test will be measured before and after 12 weeks of intervention

    Time frame: Change from baseline in walking distance at 12 weeks

  7. March in place

    Two-minute step test will be measured before and after 12 weeks of intervention

    Time frame: Change from baseline in the number of the steps at 12 weeks

  8. Subjective measurement of walking capacity

    Walking impairment questionnaire will be measured before and after 12 weeks of intervention

    Time frame: Change from baseline in the walking impairment questionnaire score after 12 weeks

  9. Subjective measurement of walking capacity compared to healthy subjects

    Walking estimated limitation calculated by history questionnaire will be measured before and after 12 weeks of intervention

    Time frame: Change from baseline in the Walking estimated limitation calculated by history questionnaire score after 12 weeks

  10. Overall strength test

    Handgrip strength test will be measured before and after 12 weeks of intervention

    Time frame: Change from baseline in kgf of the handgrip test after 12 weeks

  11. Symptoms of intermittent claudication

    The Baltimore Activity Scale for Intermittent Claudication is a questionnaire that will be measured before and after 12 weeks of intervention.

    Time frame: Change from baseline in the Baltimore Activity Scale for Intermittent Claudication score after 12 weeks

  12. General functional capacity

    The Short Physical Performance Battery will be measured before and after 12 weeks of intervention.

    Time frame: Change from baseline in the Short Physical Performance Battery score after 12 weeks

  13. Specific quality of life of vascular patients

    The Vascular quality of life questionnaire will be measured before and after 12 weeks of intervention.

    Time frame: Change from baseline in the Vascular quality of life questionnaire score after 12 weeks

  14. General quality of life

    The World Health Organization Quality of Life questionnaire will be measured before and after 12 weeks of intervention

    Time frame: Change from baseline in the World Health Organization Quality of Life score after 12 weeks

08

Study locations

1 site
  • Hospital Israelita Albert Einstein
    São Paulo, São Paulo 05652-900, Brazil
09

References and documents

Publications

  • Cavalcante BR, Ritti-Dias RM, Soares AH, Lima AH, Correia MA, De Matos LD, Gobbi F, Leicht AS, Wolosker N, Cucato GG. A Single Bout of Arm-crank Exercise Promotes Positive Emotions and Post-Exercise Hypotension in Patients with Symptomatic Peripheral Artery Disease. Eur J Vasc Endovasc Surg. 2017 Feb;53(2):223-228. doi: 10.1016/j.ejvs.2016.11.021. Epub 2016 Dec 21. PubMed 28012910 ↗
  • Costa RM, Kanegusuku H, Cucato GG, Wolosker N, Ritti-Dias RM, Correia MA. Arm Crank Exercise Training Improves Ambulatory Blood Pressure in Patients With Symptomatic Peripheral Artery Disease: Randomized Controlled Trial. J Cardiopulm Rehabil Prev. 2024 Mar 1;44(2):145-147. doi: 10.1097/HCR.0000000000000829. Epub 2023 Nov 30. No abstract available. PubMed 38032247 ↗
  • Jansen SC, Abaraogu UO, Lauret GJ, Fakhry F, Fokkenrood HJ, Teijink JA. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev. 2020 Aug 20;8(8):CD009638. doi: 10.1002/14651858.CD009638.pub3. PubMed 32829481 ↗

Individual participant data

Plan to share: Yes — We are planing to share our data in the future.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: After publication of the main paper.

Access criteria: Ask to authors permision.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2019 to primary completion in Nov 2025, 77 months.

Of 73 non-industry interventional studies with no phase under Intermittent Claudication, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 77. This study's 77 months is above that.

Counting every sponsor, half of 84 studies reached it within 41 months; a quarter within 17 and three quarters within 77.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: start Jun 2019 → May 2019, primary completion Dec 2022 → Nov 2025 and completion Dec 2023 → Nov 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 7, 2019
First posted
Feb 12, 2019
StartActual
May 24, 2019was Jun 2019
Primary completionActual
Nov 11, 2025was Dec 2022
CompletionActual
Nov 11, 2025was Dec 2023
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 3, 2026
Sites
1 site added, 1 site removed
Show site
  • Hospital Israelita Albert Einstein · São Paulo, Brazil
Show 1 removed
  • Hospital Israelita Albert Einstein · São Paulo, Brazil
Nov 3, 2026
Start date
Jun 10, 2019→May 24, 2019
Nov 3, 2026
Primary completion
Dec 10, 2022→Nov 11, 2025 (actual)
Nov 3, 2026
Study completion
Dec 10, 2023→Nov 11, 2025 (actual)
Nov 3, 2026
Enrollment
45 (estimated)→90 (actual)
Nov 3, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 38032247 ↗
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Status unknown→Completed
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 38032247 ↗
    1 site added, 1 site removed
    Show site
    • Hospital Israelita Albert Einstein · São Paulo, Brazil
    Show 1 removed
    • Hospital Israelita Albert Einstein · São Paulo, Brazil
    Start date Jun 10, 2019→May 24, 2019
    Primary completion Dec 10, 2022→Nov 11, 2025 (now actual)
    Study completion Dec 10, 2023→Nov 11, 2025 (now actual)
    Enrollment 45 (estimated)→90 (actual)
    + 3 other changes: verification date, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03837639
Responsible party
Sponsor
First posted
Feb 12, 2019
Start date
May 24, 2019
Primary completion
Nov 11, 2025
Completion
Nov 11, 2025
Last update
Nov 3, 2026

Study contacts

Hélcio Kanegusuku, PhD
study chair · Israelite Institute for Education and Research

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion